We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Quince Therapeutics Inc | NASDAQ:QNCX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0245 | -2.55% | 0.9355 | 0.9212 | 0.95 | 0.99 | 0.9211 | 0.96 | 113,736 | 18:06:23 |
FORM 3
|
Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person * EPIQ Capital Group, LLC |
2. Date of Event Requiring Statement (MM/DD/YYYY)
|
3. Issuer Name and Ticker or Trading Symbol Cortexyme, Inc. [CRTX] |
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
_____ Officer (give title below) ___ X ___ Other (specify below) / IA/Managing Member 10% owner |
|
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned |
|||
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock | 1750000 | I (1) | Managing Member of EPQ LLC, CTYM PS |
Common Stock | 936309 | I (1) | Managing Member of CTEPQ Partners LLC |
Common Stock | 120070 | I (1) | By Mr. Boeding as Managing Member of Wyntoon Partners LLC |
Common Stock | 9003 | I (1) | By Mr. Boeding as Trustee of Boeding Family Trust |
Common Stock | 1814 | D (1) (2) | |
Common Stock | 1000 | I (1) | By Mr. Boeding's spouse |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
EPIQ Capital Group, LLC
ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO, CA 94111 |
|
|
|
IA/Managing Member 10% owner | |
Boeding Chad
ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO, CA 94111 |
|
X |
|
|
Signatures
|
||
Chad Boeding as Managing Member of EPIQ Capital Group LLC | 6/14/2019 | |
** Signature of Reporting Person | Date | |
Chad Boeding | 6/14/2019 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Quince Therapeutics Chart |
1 Month Quince Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions